Delivery Order SPE2DR25D2014-SPE2DR26FZ70V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 count) with a contract ceiling value of $2,328.28. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yuvafem 10 MCG vaginal inserts (18-count units) with a ceiling value of $3,966.96. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and requires completion by September 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action...
- The Defense Logistics Agency awarded a delivery order valued at $3,543.42 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count units) at a firm fixed price of $1,477.02. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Yuvafem 10 mcg Vaginal Insert (8-count packages) with a contract ceiling value of $8,089.78. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The order is scheduled for ultimate completion on October 21, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a $1,748.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (8-count packaging). The delivery order, which concludes on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Yuvafem 10 micrograms vaginal inserts (18 units) under a firm fixed-price contract valued at $1,741.75. This is a non-set-aside competitive award with an ultimate completion date of August 12, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,467.14 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for Yuvafem 10 mcg vaginal inserts (18 count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and is scheduled for completion by October 29, 2025, with performance at AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.25 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and runs through December 2026. The product...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ70VDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count) with a ceiling value of $3,694.08 under a firm fixed price contract. This non-set-aside delivery order, with an ultimate completion date of November 17, 2025, represents a purchase of pharmaceutical products to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving the federal government, AmerisourceBergen has demonstrated capability to fulfill competitive procurement requirements across the Defense Health Agency's medical supply chain through a comprehensive vehicle supporting military healthcare programs globally. The delivery order reflects the company's established role as a critical vendor for specialized pharmaceutical products across multiple therapeutic domains within the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/14/25 |